Produkty 23740-14-9

CAS 23740-14-9 występuje w naszej ofercie pod nazwami: 25R-3Alpha,7Alpha,12Alpha-Trihydroxy-5Beta-cholestanoic Acid, >95% (HPLC), 25R-3a,7a,12a-Trihydroxy-5b-cholestanoic Acid, >95% (HPLC), 25R-3α,7α,12α-Trihydroxy-5β-cholestanoic acid. Oferty producentów: TRC, Biosynth. Dostępne opakowania: 10mg, 25mg, 50mg.

25R-3Alpha,7Alpha,12Alpha-Trihydroxy-5Beta-cholestanoic Acid, >95% (HPLC)
TRC
  • opakowanie: 10mg
  • Warianty: 1
Zobacz produkt
25R-3a,7a,12a-Trihydroxy-5b-cholestanoic Acid, >95% (HPLC)
TRC
  • opakowanie: 25mg
  • Warianty: 1
Zobacz produkt
25R-3α,7α,12α-Trihydroxy-5β-cholestanoic acid
Biosynth
  • opakowanie: 25mg, 10mg, 50mg
  • Warianty: 3
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2R,6R)-2-methyl-6-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid (CAS 23740-14-9) to związek chemiczny o wzorze sumarycznym C27H46O5 i masie molowej 450.7 g/mol. Nazwa systematyczna IUPAC: (2R,6R)-2-methyl-6-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid. InChIKey: CNWPIIOQKZNXBB-WBYPBBSPSA-N.

Dane identyfikacyjne
Wzór sumarycznyC27H46O5
Masa molowa450.7 g/mol
Nazwa IUPAC(2R,6R)-2-methyl-6-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid
InChIKeyCNWPIIOQKZNXBB-WBYPBBSPSA-N
SMILESC[C@H](CCC[C@@H](C)C(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: (25R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oic acid, (3alpha,5beta,7alpha,12alpha,25R)-3,7,12-trihydroxycholestan-26-oic acid, 25R-3a,7a,12a-Trihydroxy-5b-cholestanoic Acid, 25R-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoic Acid, 25R-3?,7?,12?-Trihydroxy-5?-cholestanoic acid
Powiązane formy tego związku
(6R)-2-methyl-6-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid C27H46O5
(6R)-2-(trideuteriomethyl)-6-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid C27H46O5
(6R)-2-methyl-6-[(3S,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid C27H46O5
Izomery (ten sam wzór sumaryczny)
(2S,4R)-4-[(3R,5S,6R,7R,8R,9S,10S,12S,13R,14S,17R)-6-ethyl-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid C27H46O5
(2R,3S,5S,8S,9S,10R,13S,14S,17R)-17-[(2S,3R,4R)-3,4-dihydroxy-6-methylheptan-2-yl]-2,3-dihydroxy-10,13-dimethyl-1,2,3,4,5,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-6-one C27H46O5